Climb Bio, Inc. Common Stock
€9.794
EUR
Last updated on --.
24h volume627.66K
24h highest9.8971 EUR
24h lowest9.4168 EUR
24h Price movement+3.64%
CLYM recent prices
24 Hours
+3.64%+€0.34368
30 days
+20.00%+€1.632
60 days
+56.84%+€3.428
90 days
+54.47%+€3.453
Key data
Previous close9.4512 EUR
Market cap517.57M EUR
Volume627.66K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.79046 EUR
Net income (FY)-45.36M EUR
Revenue (FY)--
Last report date7 May 2026
About Climb Bio, Inc. Common Stock
HeadquartersWELLESLEY HILLS
Employees (FY)29.00
Net income per employee (FY)-1.56M EUR
Listed onNasdaq
CLYM conversion tables
 |  |
|---|---|
| 0.5 CLYM | 4.897 EUR |
| 1 CLYM | 9.794 EUR |
| 5 CLYM | 48.97 EUR |
| 10 CLYM | 97.94 EUR |
| |
|---|---|
| 0.5 EUR | 0.051047 CLYM |
| 1 EUR | 0.10209 CLYM |
| 5 EUR | 0.51047 CLYM |
| 10 EUR | 1.020 CLYM |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
CLYM is trading at €9.794, +3.64% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CLYM stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CLYM is currently trading at €9.794, +3.64% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CLYM price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CLYM's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CLYM; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CLYM's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Climb Bio, Inc. Common Stock's market cap is currently 517.57M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume627.66K
24h highest9.8971 EUR
24h lowest9.4168 EUR
24h Price movement+3.64%
Start trade with CLYM Perpetual
Sign up to trade